Search Ontology:
ChEBI
savolitinib
- Term ID
- CHEBI:231369
- Synonyms
-
- 1-[(1S)-1-(imidazo[1,2-a]pyridin-6-yl)ethyl]-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine
- 1-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-6-(1-methyl-1H-pyrazol-4-yl)-1H-1,2,3-triazolo[4,5-b]pyrazine
- 3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine
- AZD 6094
- AZD-6094
- AZD6094
- HM 5016504
- HM-5016504
- HMPL 504
- HMPL-504
- Orpathys
- savolitinib
- savolitinibum
- volitinib
- Definition
- A member of the class of triazolopyrazines that is 1H-[1,2,3]triazolo[4,5-b]pyrazine substituted by (1S)-1-(imidazo[1,2-a]pyridin-6-yl)ethyl and 1-methyl-1H-pyrazol-4-yl groups at positions 1 and 6, respectively. It is a highly selective MET tyrosine kinase inhibitor that is approved in China for advanced NSCLC with MET exon 14 skipping mutations.
- References
-
- cas:1313725-88-0
- drugbank:DB12048
- kegg.drug:D11139
- pdb-ccd:V0L
- pubmed:25148209
- pubmed:25779944
- pubmed:28644771
- pubmed:29191878
- pubmed:30952639
- pubmed:31531204
- pubmed:31564914
- pubmed:32027846
- pubmed:32469384
- pubmed:33052556
- pubmed:33125717
- pubmed:33400845
- pubmed:34455538
- pubmed:34590028
- pubmed:36333268
- pubmed:36339926
- pubmed:36551608
- pubmed:36808891
- pubmed:36809050
- pubmed:36811415
- pubmed:36846984
- pubmed:36888921
- pubmed:36944506
- pubmed:37078211
- pubmed:37293311
- pubmed:37315260
- pubmed:37564044
- pubmed:37835402
- pubmed:38023194
- pubmed:38145112
- pubmed:38181277
- pubmed:38182507
- pubmed:38276867
- pubmed:38313385
- pubmed:38380365
- pubmed:38385995
- pubmed:38525101
- pubmed:38599970
- wikipedia.en:Savolitinib
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from savolitinib
Phenotype where environments contain savolitinib
Phenotype modified by environments containing savolitinib
Phenotype affecting savolitinib
Human Disease Model